Joint

The Joint Corp. engages in the development, ownership, operation, support, and management of chiropractic clinics. It operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment consists of the operating activities of the company-owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar, and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Joint (JYNT) posts record sales in Q4 2022, eyes strategic growth

Joint (JYNT) delivered strong financial performance in Q4 2022, driven by record clinic openings and successful marketing initiatives.
While facing challenges such as labor costs and franchise sales impact, the company is focused on margin expansion and strategic growth opportunities.
With a positive outlook for 2023 revenue and adjusted EBITDA, Joint (JYNT) aims to navigate challenges and capitalize on opportunities for sustained success.
The company's commitment to patient care, operational efficiency, and financial planning positions it well for future growth and profitability.

Joint Corp. posts impressive Q1 results amidst digital marketing evolution

Joint Corp. delivered robust Q1 2023 results with strong sales growth and operational performance across its clinic network.
While facing competitive pressures and marketing challenges, the company's focus on efficiency and patient acquisition strategies bodes well for future growth.
Adapting to digital marketing trends and leveraging upcoming events can position Joint Corp. for sustained success and investor confidence.

Joint (JYNT) reports strong Q2 growth, focuses on profitability

Joint (JYNT) reported solid growth in system-wide sales and clinic openings, with profitability around 20% despite challenges.
The company is actively addressing operational issues, optimizing its clinic portfolio, and focusing on cost savings initiatives.
Strategic planning for profitability and efficiency in 2024 and beyond is underway, with a commitment to long-term success.
Partnerships, marketing expansions, and ongoing reviews present opportunities for growth and market expansion for Joint (JYNT).

The Joint Corp. reports stable Q3 earnings, shifts focus to franchises

The Joint Corp. delivered solid financial performance in Q3 2023, with a focus on refranchising and enhancing franchise clinic operations.
Efforts to boost new patient starts and optimize marketing strategies are driving positive trends in conversion rates and sales.
While facing challenges in new patient counts and franchise sales, the company is strategically positioning itself for long-term success.

The Joint Corp. reports robust 2023 performance and strategic growth plans

The Joint Corp. delivered strong financial performance in 2023, with notable growth in sales, revenue, and patient metrics.
Strategic initiatives like refranchising and local store marketing offer growth opportunities and cost-saving potential for the company.
Challenges include managing the transition of company-owned clinics and balancing marketing expenses with revenue growth objectives.
Overall, The Joint Corp. is well-positioned to capitalize on its operational strengths and market opportunities for sustained growth and success.

The Joint Corp. triples franchise sales and boosts financial performance

The Joint Corp. delivered strong financial performance in Q1 2024, marked by revenue growth, improved bottom line, and significant franchise sales growth, supported by robust marketing strategies.
While facing potential risks and challenges, the company's focus on EBITDA, franchise expansion, and talent development positions it well for future growth and operational excellence.
Opportunities in marketing innovation, talent development, and operational efficiency present avenues for sustained growth and value creation, aligning with the company's commitment to performance and brand enhancement.
Overall, The Joint Corp.'s Q1 2024 earnings call highlighted a strategic roadmap for success, emphasizing growth, excellence in patient care, and financial transparency to drive shareholder value.

The Joint Corp. reports revenue growth and strategic focus on clinics

The Joint Corp. reported positive revenue growth in Q2 2024, driven by same-store comps and operational improvements.
While facing financial challenges and impact on franchise sales, the company's strategic focus on clinic optimization and patient loyalty is a key strength.
Future opportunities lie in expanding the clinic network, enhancing profitability, and driving patient loyalty through innovative strategies.
Overall, The Joint Corp. is positioned for growth with a strong foundation of clinics and a focus on improving financial performance and patient experiences.

Joint Corp (JYNT) reports robust Q3 performance amidst operational enhancements

Joint Corp's Q3 2024 earnings call highlighted strong performance metrics, a strategic focus on patient care and operational efficiency, and challenges related to consumer headwinds and refranchising efforts. The company is well-positioned to capitalize on growth opportunities by leveraging its infrastructure and exploring new service offerings.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The Joint Corp. engages in the development, ownership, operation, support, and management of chiropractic clinics. It operates through the Corporate Clinics and Franchise Operations segments. The Corporate Clinics segment consists of the operating activities of the company-owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar, and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.

Does The Joint Corp. (JYNT) have what it takes to be a top stock pick for momentum investors?

The Joint Corp. (JYNT) Is Up 9.28% in One Week: What You Should Know

Shares have skyrocketed since my recommendation to buy in May 2016.

The Joint: Wind At Its Back

Molina Healthcare

MOH vs. JYNT: Which Stock Is the Better Value Option?

Molina vs. The Joint Corp.

The Joint Corp. (JYNT) CEO Peter Holt on Q1 2019 Results - Earnings Call Transcript

News for Joint Stock (JYNT)